Status:

RECRUITING

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Eligibility Criteria

Inclusion

  • Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):
  • Breast cancer survivor, patient advocate or key healthcare personnel
  • Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  • \>12 months of employment at the affiliated institution
  • Administrative or clinical involvement in the delivery of breast cancer care services.
  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Participant and/or LAR willing and able to consent
  • Fluent in Swahili and/or English by self-report
  • Participant Exclusion Criteria:
  • Key stakeholder not residing at their particular institutions during data collection will be excluded.
  • Eligibility criteria for Chart Reviews (Aim 1)
  • Inclusion Criteria for chart review:
  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Received breast cancer diagnosis
  • Exclusion Criteria for chart review:
  • Participants less than 18 years of age

Exclusion

    Key Trial Info

    Start Date :

    April 13 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2026

    Estimated Enrollment :

    85 Patients enrolled

    Trial Details

    Trial ID

    NCT05438511

    Start Date

    April 13 2023

    End Date

    April 1 2026

    Last Update

    August 5 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York, United States, 10065

    2

    Muhimbili University of Health and Allied Sciences

    Dar es Salaam, Tanzania